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Abstract
IMPORTANCE—More than one-third of adults and 17% of youth in the United States are obese, 
although the prevalence remained stable between 2003–2004 and 2009–2010.
OBJECTIVE—To provide the most recent national estimates of childhood obesity, analyze 
trends in childhood obesity between 2003 and 2012, and provide detailed obesity trend analyses 
among adults.
DESIGN, SETTING, AND PARTICIPANTS—Weight and height or recumbent length were 
measured in 9120 participants in the 2011–2012 nationally representative National Health and 
Nutrition Examination Survey.
MAIN OUTCOMES AND MEASURES—In infants and toddlers from birth to 2 years, high 
weight for recumbent length was defined as weight for length at or above the 95th percentile of the 
sex-specific Centers for Disease Control and Prevention (CDC) growth charts. In children and 
adolescents aged 2 to 19 years, obesity was defined as a body mass index (BMI) at or above the 
95th percentile of the sex-specific CDC BMI-for-age growth charts. In adults, obesity was defined 
as a BMI greater than or equal to 30. Analyses of trends in high weight for recumbent length or 
obesity prevalence were conducted overall and separately by age across 5 periods (2003–2004, 
2005–2006, 2007–2008, 2009–2010, and 2011–2012).
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RESULTS—In 2011–2012, 8.1% (95% CI, 5.8%–11.1%) of infants and toddlers had high weight 
for recumbent length, and 16.9% (95% CI, 14.9%–19.2%) of 2- to 19-year-olds and 34.9% (95% 
CI, 32.0%–37.9%) of adults (age-adjusted) aged 20 years or older were obese. Overall, there was 
no significant change from 2003–2004 through 2011–2012 in high weight for recumbent length 
among infants and toddlers, obesity in 2- to 19-year-olds, or obesity in adults. Tests for an 
interaction between survey period and age found an interaction in children (P = .03) and women 
(P = .02). There was a significant decrease in obesity among 2- to 5-year-old children (from 
13.9% to 8.4%; P = .03) and a significant increase in obesity among women aged 60 years and 
older (from 31.5% to 38.1%; P = .006).
CONCLUSIONS AND RELEVANCE—Overall, there have been no significant changes in 
obesity prevalence in youth or adults between 2003–2004 and 2011–2012. Obesity prevalence 
remains high and thus it is important to continue surveillance.
Obesity and childhood obesity, in particular, are the focus of many public health efforts in 
the United States.1,2 New regulations have been implemented by the US Department of 
Agriculture for food packages in the Special Supplemental Nutrition Program for Women, 
Infants and Children,3 the Centers for Disease Control and Prevention (CDC) has funded 
state- and community-level interventions,4 and there have been numerous reports and 
recommendations issued by the Institute of Medicine,5 the US Surgeon General,6 and the 
White House.1 Although the prevalence of obesity in the United States is high, with one-
third of adults and 17% of children obese,7 it appears to have leveled off between 2003–
2004 and 2009–2010.8,9 Given the focus of public health efforts on obesity, surveillance of 
trends in obesity remains important.
The purpose of this study is to provide the most recent national estimates of childhood 
obesity and analyze trends in childhood obesity between 2003 and 2012. In addition, as a 
follow-up to recently published estimates of adult obesity,10 more detailed trend analyses by 
age are presented. Estimates of overweight prevalence are also presented but are not 
analyzed for trends because overweight prevalence showed no trends between 1960 and 
2010.11 Analyses are based on measured values of weight and height from the 2011–2012 
National Health and Nutrition Examination Survey (NHANES).
Methods
A detailed description of NHANES is available elsewhere.12 It is a cross-sectional, complex, 
probability sample of the US non-institutionalized population, with both interview and 
examination components. Although each year represents a nationally representative sample, 
data are released every 2 years to ensure adequate sample size for analyses and protect 
confidentiality. The most recent data presented in this analysis are from 2011–2012, and 
trends were analyzed between 2003–2004 and 2011–2012 with 5 time periods. In 2011–
2012, 70% of individuals selected for the survey participated in its examination component 
compared with 76% in 2003–2004, 77% in 2005–2006, 75% in 2007–2008, and 77% in 
2009–2010.13
NHANES includes oversampling of different subpopulations, including specific race/
Hispanic origin groups. In 2011–2012, Hispanics, non-Hispanic blacks, and non-Hispanic 
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Asians were oversampled. Oversampling of non-Hispanic Asians is a new addition to the 
NHANES survey. In the collection of NHANES data, survey participants were asked to 
report their race and whether they were of Hispanic origin. Individuals who reported they 
were of Hispanic origin were categorized as Hispanic regardless of their race. If they were 
not of Hispanic origin, they were categorized into 4 different groups (non-Hispanic white, 
non-Hispanic black, non-Hispanic Asian, and other). All non-Hispanic individuals who 
reported more than 1 race group were included in the “other” group, which was included in 
calculations of the total population but not reported separately.
During the NHANES physical examination, weight and height were measured in a 
standardized fashion.12 For children younger than 2 years, recumbent length was measured 
instead of standing height. In 2011–2012, 1.5% (141) of examined participants were missing 
weight and height or length measurements.
The National Center for Health Statistics Research Ethics Review Board approved 
NHANES. Written parental permission was obtained for minors younger than 18 years. 
Children aged 7 to 17 years were also asked to provide documented assent. Written consent 
was obtained for all adults aged 18 years and older.
Weight status for individuals aged 2 years and older was defined with body mass index 
(BMI, measured as weight in kilograms divided by height in meters squared) rounded to 1 
decimal place. In children and adolescents aged 2 to 19 years, obesity was defined as a BMI 
at or above the 95th percentile of the CDC sex-specific BMI-for-age growth charts from 
2000.14,15 Overweight was defined as a BMI between the 85th and 95th percentiles. The 
estimates are presented as greater than or equal to both the 85th and 95th percentiles. 
Because there is no recommended definition of obesity in children younger than 2 years, 
excess weight was defined as a weight for recumbent length at or above the 95th percentile 
on the CDC sex-specific weight for recumbent length growth charts, similar to what has 
been presented in previous analyses.9 The World Health Organization (WHO) growth 
standards have been recommended to monitor growth in children younger than 2 years in the 
United States.16 Consequently, the percentage of infants and toddlers at or above the 97.7th 
percentile of WHO weight for recumbent length growth standards16 also is presented.
In adults aged 20 years and older, obesity was defined as a BMI greater than or equal to 30. 
Obesity was further divided into grade 1 (BMI 30–34), grade 2 (BMI 35–39), and grade 3 
(BMI ≥40). Overweight among adults was defined as a BMI greater than or equal to 25 but 
less than 30. The estimates are presented as BMI greater than or equal to 25, 30, 35, and 40.
Prevalence estimates are presented with 95% CIs, which were constructed with the logit 
transformation.17 Differences in prevalence between male and female participants overall in 
2011–2012 were tested separately in infants, children, and adults at the α = .05 level, using 
2-sided t tests. To test for race/Hispanic origin and age differences in 2011–2012, the null 
hypothesis of no race/ethnic or age difference was first tested with an analysis of variance. If 
this hypothesis was rejected, tests for differences between any 2 subgroups were conducted 
with t tests. Tests for differences by race/Hispanic origin were evaluated by comparing the 4 
race/Hispanic origin groups described above. Tests for differences by age in children were 
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evaluated with the following comparisons: aged 2 to 5 vs 6 to 11 years, 2 to 5 vs 12 to 19 
years, and 6 to 11 vs 12 to 19 years. Similarly, in adults comparisons were made between 
aged 20 to 39 and 40 to 59 years, 20 to 39 and 60 years or older, and 40 to 59 and 60 years 
or older. P values for test results are shown in the text but not the tables. Adjustments were 
not made for multiple comparisons.
Trends in the unadjusted prevalence of high weight for recumbent length or obesity from 
2003–2004 through 2011–2012 (using 5 time periods: 2003–2004, 2005–2006, 2007–2008, 
2009–2010, and 2011–2012) were tested with t statistics and orthogonal contrast matrices. 
Trends were analyzed separately for infants, children, and adults because of different 
definitions. P values for trends, along with the absolute change in obesity prevalence 
between 2003–2004 and 2011–2012, are reported.
Trends in high weight for recumbent length or obesity were also tested in logistic regression 
models adjusted for age and race/Hispanic origin with the Satterwaite adjusted F statistic.18 
We found a significant interaction between survey period and age among youth and adult 
women, so we conducted sex- and age-specific logistic regression models of obesity 
adjusted for race/Hispanic origin (results shown in the Supplement). Survey period was 
treated as a continuous variable.
Analyses were conducted with SAS version 9.3 and SUDAAN version 11.0. All analyses 
used NHANES examination sample weights that adjust for nonresponse, noncoverage, and 
unequal probabilities of selection. Standard errors were estimated with Taylor series 
linearization to take into account the complex sample design. Pregnant females were 
excluded from all analyses. Obesity estimates for total adults aged 20 years and older were 
age standardized to the projected estimates of the 2000 US Census by the direct method, 
using the age groups 20 to 39 years, 40 to 59 years, and 60 years and older. Crude estimates 
of obesity among all adults are also presented.
Results
There were 9120 persons with measured weights and heights (or recumbent length) in 
NHANES 2011–2012. More than half of these (5181) were adults aged 20 years and older 
and 584 were infants and toddlers. Of the 9120 respondents, 1179 were non-Hispanic Asian. 
Detailed sample sizes by sex, age, and race/Hispanic origin are shown in Table 1.
The prevalence of high weight for recumbent length among infants and toddlers from birth 
to aged 2 years was 8.1% (95% CI, 5.8%–11.1%) (Table 2). There was a significant 
difference between boys and girls; 5% of boys (95% CI, 3.5%–7.0%) and 11.4% of girls 
(95% CI, 7.3%–17.4%) had high weight for recumbent length (P = .03). There were no 
significant differences between the race/Hispanic origin groups (P = .32). When WHO 
growth charts were used to define excess weight for recumbent length, 7.1% (95% CI, 
4.9%–10.3%) of infants and toddlers had high weight for recumbent length (Table 2).
In 2011–2012, 31.8% (95% CI, 29.1%–34.7%) of youth were either overweight or obese, 
and 16.9% (95% CI, 14.9%–19.2%) of youth were obese (Table 3). In 2011–2012, there was 
no difference in obesity prevalence between boys and girls (P = .77), but there were race/
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Hispanic origin (P = .001, analysis of variance) and age (P < .001, analysis of variance) 
differences. The prevalence of obesity was lower in non-Hispanic Asian youth (8.6%; 95% 
CI, 5.7%–12.7%) than in youth who were non-Hispanic white (14.1%; 95% CI, 10.8%–
18.2%; P = .04), non-Hispanic black (20.2%; 95% CI, 16.7%–24.2%; P < .001), or Hispanic 
(22.4%; 95% CI, 20.3%–24.6%; P < .001). The prevalence of obesity was also lower among 
non-Hispanic white youth compared with non-Hispanic black youth (P = .048) and Hispanic 
youth (P < .001). There was no difference in prevalence between non-Hispanic black youth 
and Hispanic youth (P = .31). More than 8% (8.4%; 95% CI, 5.9%–11.6%) of 2- to 5-year-
olds were obese compared with 17.7% (95% CI, 14.5%–21.4%) of 6- to 11-year-olds (P < .
001) and 20.5% (95% CI, 17.1%–24.4%) of 12- to 19-year-olds (P < .001). There was no 
difference in obesity prevalence between 6- to 11- and 12- to 19-year-olds (P = .22). 
Additional information on the unweighted number of participants with high weight for 
recumbent length or who were obese is detailed in eTable 1 in the Supplement. The 
percentage of adolescents aged 12 to 19 years with BMI greater than or equal to 30, meeting 
the adult definition of obesity, was 13.9% (95% CI, 10.9%–17.7%) in 2011–2012.
Age-adjusted and crude prevalence estimates of overweight and obesity among adults by 
sex, age, and race/Hispanic origin are shown in Tables 4 and 5. The age-adjusted estimates 
indicate that more than two-thirds (68.5%; 95% CI, 65.2%–71.6%) of adults were either 
overweight or obese, 34.9% (95% CI, 32.0%–37.9%) were obese, and 6.4% (95% CI, 5.2%–
7.7%) were extremely obese (grade 3 obesity) in 2011–2012. There were significant 
differences by sex, age, and race/Hispanic origin. For example, the prevalence of grade 3 
obesity differed by sex (P = .004), with the prevalence higher in women (8.3%; 95% CI, 
6.9%–9.8%) than men (4.4%; 95% CI, 2.8%–6.8%), and by age (P = .03), with the 
prevalence highest among the middle-age group (7.7%; 95% CI, 6.2%–9.4%) compared 
with 20- to 39-year-olds (5.6%; 95% CI, 4.4%–7.1%) and adults aged 60 years or older 
(5.6%; 95% CI, 3.8%–8.0%). The prevalence of grade 3 obesity also varied by race/
Hispanic origin (P < .001), with the highest prevalence among non-Hispanic black adults 
(12.1%; 95% CI, 10.3%–14.0%) compared with 5.6% (95% CI, 4.1%–7.5%) in non-
Hispanic white adults, 0.9% (95% CI, 0.3%–2.3%) in non-Hispanic Asian adults, and 5.8% 
(95% CI, 4.7%–7.1%) in Hispanic adults.
Results of linear unadjusted trend tests between 2003–2004 and 2011–2012 are shown in 
Table 6. Among infants and toddlers from birth to aged 2 years, there was no significant 
change in high weight for length prevalence (−1.4 percentage points; P = .72). Among 
children and adolescents aged 2 to 19 years, there was no significant change overall (−0.2 
percentage points; P = .78), but there was a significant decrease in obesity prevalence 
among 2- to 5-year-old children (−5.5 percentage points; P = .03). Among adults, there was 
no significant change in obesity prevalence in the total population (+2.8 percentage points; P 
= .09), but there was an increase in prevalence among adults aged 60 years and older (+4.4 
percentage points; P = .004).
Sex- and age-specific unadjusted trend results are shown in eTable 2 in the Supplement. In 
these analyses, the only significant trends were found in women aged 60 years and older (6.6 
percentage point increase: 31.5% to 38.1%; P = .006); there was no significant trend among 
men aged 60 years and older (P = .25). Among girls aged 2 to 5 years, there was a 5.5 
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percentage point decrease in obesity prevalence, although it was not significant (P = .07). In 
sex and race/Hispanic origin adjusted analyses of trends, results were similar to those in the 
unadjusted analyses (eTable 3 in the Supplement). Tests for an interaction between survey 
period and age found an interaction in children (P = .03) and women (P = .02).
Discussion
In 2011–2012, the prevalence of obesity in the United States was 16.9% in youth and 34.9% 
in adults. The overall prevalence of obesity among youth remained unchanged compared 
with that in 2009–2010 (16.9%),9 and there was no significant change since 2003–2004. 
Similarly, there was no significant change in obesity prevalence among adults between 
2003–2004 and 2011–2012. In subgroup analyses, the prevalence of obesity among children 
aged 2 to 5 years decreased from 14% in 2003–2004 to just over 8% in 2011–2012, and the 
prevalence increased in women aged 60 years and older, from 31.5% to more than 38%. 
Because these age subgroup analyses and tests for significance did not adjust for multiple 
comparisons, these results should be interpreted with caution.
Newly available estimates of obesity among non-Hispanic Asians show that almost 9% of 
non-Hispanic Asian youth and 10.9% of non-Hispanic Asian adults were obese according to 
BMI cut points. BMI, however, is not a perfect measure of body fat.19 It is highly correlated 
with body fat but does not account for differences in distribution of body fat or differences 
between race/Hispanic origin groups, sex, and age. Different sex, age, and race/ethnicity 
groups may have different body fat at the same BMI.20,21 For example, some research 
suggests that Asians may have more body fat than whites, especially at lower BMIs.22 Risk 
of morbidity and mortality may not be completely captured by BMI.23 Given concerns that 
health risks begin at a lower BMI among Asians compared with others, some Asian 
countries have adopted lower cut points of BMI to define overweight or obesity,24 and 
although WHO has recommended continuing to use the standard cutoffs for international 
comparisons, a WHO expert committee has recommended lower cutoffs for Asians as points 
for “public health action.”25
The prevalence of high weight for recumbent length with the CDC growth charts is slightly 
higher than the prevalence with WHO growth standards. Overall, among infants and 
toddlers from birth to aged 2 years, 8.1% were at or above the 95th percentile of sex-specific 
CDC weight for recumbent length growth charts, whereas 7.1% were at or above the 97.7th 
percentile on the corresponding WHO growth charts. For all groups (sex and race/Hispanic 
origin), the estimates were slightly higher with the CDC growth charts than WHO growth 
standards. The 2 sets of growth charts differ in that the CDC charts represent a growth 
reference based on the general US population in the 1970s, 1980s, and early 1990s.15 WHO 
growth standards, on the other hand, represent growth of children in select settings around 
the world with optimal feeding practices, among other factors.26
Recent decreases in the prevalence of obesity have been reported in some populations of 
youth in the United States. Between 2008 and 2011, significant decreases were reported 
among low-income preschool-aged children participating in federal nutrition programs in 18 
states and the US Virgin Islands. The absolute decreases ranged from 0.3 to 2.6 percentage 
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points.27 Similarly, between 2003 and 2008 a decrease in obesity prevalence among children 
younger than 6 years was reported in a multisite pediatric practice in eastern 
Massachusetts.28 The decrease we observed among preschool-aged children is consistent 
with the decreases observed in low-income children in the United States overall and in some 
states individually.
Analyses of trends in obesity prevalence among middle and high school students have 
shown mixed results. Among public middle school students in New York City, a recent 
analysis found a decrease in obesity prevalence between 2006–2007 and 2010–2011.29 
Other researchers using a school-based survey found an increase in obesity prevalence 
among US adolescents between 2001–2002 and 2005–2006 but no change between 2005–
2006 and 2009–2010.30 In addition, data from the Youth Risk Behavior Surveillance System 
showed an increase in the prevalence of obesity between 1999 and 2011 but no change 
between 2009 and 2011.31 NHANES results among middle school– and high school–aged 
children show no significant change in prevalence between 2003–2004 and 2011–2012.
Data from many countries have shown a decline or stabilization of obesity levels, especially 
in children.32 For example, in Germany a study of children aged 4 to 16 years found a 
significant decline in overweight or obesity between 2004 and 2008 among the youngest 
children (aged 4–7 years) and a stabilization in other ages.33 In England, the rate of increase 
in adult BMI has decreased.34
Analysis of time trends depends on what is chosen as the initial point of examination. In this 
analysis, we selected 2003–2004 as the starting point because previous analyses had shown 
no change in sex- or race/Hispanic origin–specific trends in obesity prevalence between 
2003–2004 and 2009–2010.8,9 The selection of the initial point can have an effect on 
findings. For example, analyses of childhood obesity trends between 1976–1980 and 2011–
2012 show an increase in childhood obesity, whereas trends between 2003–2004 and 2011–
2012 do not.
In the current analysis, trend tests were conducted on different age groups. When multiple 
statistical tests are undertaken, by chance some tests will be statistically significant (eg, 5% 
of the time using α of .05). In some cases, adjustments are made to account for these 
multiple comparisons, and a P value lower than .05 is used to determine statistical 
significance. In the current analysis, adjustments were not made for multiple comparisons, 
but the P value is presented.
Conclusions
Overall, there have been no significant changes in obesity prevalence in youth or adults 
between 2003–2004 and 2011–2012. Obesity prevalence remains high and thus it is 
important to continue surveillance.
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Table 2
Prevalence of High Weight for Recumbent Length, Birth to 2 Years, United States, 2011–2012a
% (95% CI)
≥95th Percentile of CDC 2000 Growth Charts ≥97.7th Percentile of WHO 2006 Growth Charts
Totalb   8.1 (5.8–11.1)   7.1 (4.9–10.3)
Sex
 Boys   5.0 (3.5–7.0)   3.5 (2.3–5.2)
 Girls 11.4 (7.3–17.4) 11.0 (7.0–16.8)
Race/ethnicity
 Non-Hispanic
  White   6.6 (3.8–11.3)
  5.5 (2.7–11.1)c
  Black   8.4 (4.6–14.9)   7.3 (3.8–13.5)
  Asian 11.8 (3.7–31.7)c,d   9.6 (2.7–28.8)c,d
 Hispanic   9.4 (5.8–14.9)
  8.8 (5.2–14.6)c
Abbreviations: CDC, Centers for Disease Control and Prevention; WHO, World Health Organization.
a
Data from the National Health and Nutrition Examination Survey; estimates are weighted.
b
Includes race/Hispanic origin groups not shown separately.
c
Relative standard error >30% (but <40%).
dNo. of cases <10.
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Table 3
Prevalence of High Body Mass Index by Selected Cut Points for Youth Aged 2 to 19 Years, by Sex, Age, and 
Race/Hispanic Origin, United States, 2011–2012a
% (95% CI)
2–19 y 2–5 y 6–11 y 12–19 y
Overweight or Obese (BMI for Age ≥85th Percentile of the CDC Growth Charts)
All race/Hispanic origin groupsb
 All 31.8 (29.1–34.7) 22.8 (18.7–27.6) 34.2 (30.1–38.5) 34.5 (30.1–39.2)
 Boys 32.0 (29.2–35.0) 23.9 (20.1–28.2) 33.2 (27.7–39.1) 35.1 (29.7–40.9)
 Girls 31.6 (27.2–36.5) 21.7 (14.6–31.0) 35.2 (29.2–41.8) 33.8 (27.9–40.4)
Non-Hispanic white
 All 28.5 (24.0–33.4) 20.9 (14.4–29.2) 29.4 (21.6–38.7) 31.2 (24.3–39.1)
 Boys 27.8 (22.5–33.8) 21.8 (14.9–30.8) 26.5 (18.2–36.8) 31.5 (21.9–42.9)
 Girls 29.2 (22.7–36.7) 19.9 (10.0–35.7) 32.7 (19.8–48.8) 31.0 (22.7–40.7)
Non-Hispanic black
 All 35.2 (30.2–40.6) 21.9 (16.7–28.2) 38.1 (30.1–46.8) 39.8 (32.9–47.2)
 Boys 34.4 (30.3–38.7) 22.2 (16.9–28.6) 39.3 (30.5–48.9) 37.3 (30.3–44.9)
 Girls 36.1 (28.7–44.4) 21.6 (14.6–30.8) 36.9 (26.9–48.1) 42.5 (31.9–53.8)
Non-Hispanic Asian
 All 19.5 (15.7–23.9)
  9.0 (4.5–17.3)c,d 19.9 (16.2–24.3) 24.6 (17.8–32.9)
 Boys 25.1 (18.7–32.8)
  8.3 (2.5–24.0)c,d 24.5 (16.6–34.5) 33.9 (23.2–46.6)
 Girls 13.7 (8.6–21.2)
  9.7 (3.3–25.0)c,d 14.9 (8.9–23.9) 15.0 (7.3–28.3)d
Hispanic
 All 38.9 (36.3–41.6) 29.8 (24.0–36.4) 46.2 (41.5–50.9) 38.1 (31.9–44.8)
 Boys 40.7 (37.3–44.1) 31.4 (23.5–40.5) 48.7 (41.1–56.3) 39.6 (31.3–48.5)
 Girls 37.0 (33.4–40.8) 28.1 (19.7–38.3) 43.6 (37.5–49.8) 36.5 (28.8–45.0)
Obese (BMI for Age ≥95th Percentile of the CDC Growth Charts)
All race/Hispanic origin groupsb
 All 16.9 (14.9–19.2)   8.4 (5.9–11.6) 17.7 (14.5–21.4) 20.5 (17.1–24.4)
 Boys 16.7 (13.9–19.8)   9.5 (6.2–14.3) 16.4 (12.9–20.6) 20.3 (15.7–25.9)
 Girls 17.2 (14.8–19.9)   7.2 (3.8–13.1) 19.1 (15.8–22.8) 20.7 (16.8–25.1)
Non-Hispanic white
 All 14.1 (10.8–18.2)
  3.5 (1.4–8.0)c,d 13.1 (7.5–22.0) 19.6 (14.1–26.5)
 Boys 12.6 (8.3–18.9)
  6.3 (2.2–17.0)c,d   8.8 (3.9–18.6)d 18.3 (10.7–29.5)
 Girls 15.6 (11.6–20.7)
  0.6 (0.1–5.0)c,d 17.9 (10.8–28.1) 20.9 (13.9–30.1)
Non-Hispanic black
 All 20.2 (16.7–24.2) 11.3 (7.3–17.1) 23.8 (17.8–31.1) 22.1 (15.8–29.9)
 Boys 19.9 (17.6–22.4)
  9.0 (3.7–20.3)d 25.9 (19.8–33.2) 21.4 (16.2–27.8)
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% (95% CI)
2–19 y 2–5 y 6–11 y 12–19 y
 Girls 20.5 (14.6–28.0) 13.9 (9.0–20.7) 21.7 (13.9–32.2) 22.7 (14.0–34.8)
Non-Hispanic Asian
 All   8.6 (5.7–12.7)
  3.4 (0.7–15.4)c,d   8.7 (5.5–13.6) 11.1 (6.7–17.8)
 Boys 11.5 (7.7–16.8)
  1.9 (0.2–18.6)c,d 13.2 (8.1–20.9)c 14.8 (8.7–24.2)
 Girls
  5.6 (2.2–13.4)d   4.7 (0.6–29.8)c,d   3.7 (0.8–14.7)c,d   7.3 (2.8–17.9)c,d
Hispanic
 All 22.4 (20.3–24.6) 16.7 (12.0–22.7) 26.1 (22.5–29.9) 22.6 (17.7–28.5)
 Boys 24.1 (21.1–27.3) 18.0 (11.7–26.8) 28.6 (22.3–35.9) 23.9 (18.2–30.6)
 Girls 20.6 (17.6–24.0) 15.2 (7.9–27.1) 23.4 (18.2–29.5) 21.3 (15.0–29.2)
Abbreviations: BMI, body mass index, calculated as weight in kilograms divided by height in meters squared; CDC, Centers for Disease Control 
and Prevention.
a
Data from the National Health and Nutrition Examination Survey; estimates are weighted.
b
Includes race/Hispanic origin groups not shown separately.
cNo. of cases <10.
d
Relative standard errors >30% but <40%.
JAMA. Author manuscript; available in PMC 2016 February 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ogden et al. Page 14
Ta
bl
e 
4
Pr
ev
al
en
ce
 o
f H
ig
h 
Bo
dy
 M
as
s I
nd
ex
 (O
ve
rw
eig
ht 
an
d O
be
sit
y) 
for
 A
du
lts
 A
ge
d 2
0 Y
ea
rs 
or 
Ol
de
r b
y S
ex
, A
ge
, a
nd
 R
ac
e/H
isp
an
ic 
Or
igi
n, 
Un
ite
d 
St
at
es
, 2
01
1–
20
12
a
%
 (9
5%
 C
I)
≥2
0 
y
20
–3
9 
y
40
–5
9 
y
≥6
0 
y
C
ru
de
A
ge
 A
dju
ste
db
O
ve
rw
ei
gh
t o
r O
be
se
 (B
M
I ≥
25
)
A
ll 
ra
ce
/H
isp
an
ic
 o
rig
in
 g
ro
up
sc
 
A
ll
69
.0
 (6
5.4
–7
2.3
)
68
.5
 (6
5.2
–7
1.6
)
60
.3
 (5
4.2
–6
6.0
)
75
.3
 (7
2.1
–7
8.2
)
71
.6
 (6
7.0
–7
5.8
)
 
M
en
71
.6
 (6
8.0
–7
5.0
)
71
.3
 (6
8.2
–7
4.2
)
62
.0
 (5
6.2
–6
7.5
)
79
.1
 (7
4.8
–8
2.8
)
74
.7
 (7
0.0
–7
8.9
)
 
W
om
en
66
.5
 (6
2.5
–7
0.2
)
65
.8
 (6
2.0
–6
9.5
)
58
.5
 (5
1.4
–6
5.2
)
71
.7
 (6
6.2
–7
6.6
)
69
.1
 (6
3.2
–7
4.5
)
N
on
-H
isp
an
ic
 w
hi
te
 
A
ll
68
.5
 (6
4.3
–7
2.5
)
67
.2
 (6
3.2
–7
1.0
)
57
.5
 (4
9.6
–6
5.1
)
74
.8
 (7
1.0
–7
8.4
)
71
.7
 (6
5.5
–7
7.1
)
 
M
en
72
.7
 (6
8.4
–7
6.6
)
71
.4
 (6
7.5
–7
5.0
)
59
.9
 (5
1.6
–6
7.7
)
80
.8
 (7
4.8
–8
5.6
)
76
.1
 (6
9.6
–8
1.6
)
 
W
om
en
64
.6
 (5
9.5
–6
9.3
)
63
.2
 (5
8.0
–6
8.2
)
 
 
 
55
 (4
5.0
–6
4.6
)
69
.1
 (6
1.5
–7
5.7
)
67
.9
 (5
9.8
–7
5.1
)
N
on
-H
isp
an
ic
 b
la
ck
 
A
ll
76
.3
 (7
2.7
–7
9.5
)
76
.2
 (7
2.6
–7
9.4
)
71
.9
 (6
5.6
–7
7.4
)
80
.3
 (7
5.2
–8
4.5
)
76
.8
 (7
1.7
–8
1.2
)
 
M
en
69
.1
 (6
4.7
–7
3.3
)
69
.2
 (6
4.7
–7
3.4
)
62
.9
 (5
4.8
–7
0.2
)
74
.4
 (6
8.5
–7
9.6
)
71
.8
 (6
5.8
–7
7.2
)
 
W
om
en
82
.1
 (7
8.4
–8
5.3
)
82
.0
 (7
8.2
–8
5.1
)
80
.0
 (7
2.6
–8
5.8
)
85
.2
 (7
8.8
–8
9.9
)
80
.2
 (7
3.2
–8
5.7
)
N
on
-H
isp
an
ic
 A
sia
n
 
A
ll
38
.2
 (3
3.9
–4
2.6
)
38
.6
 (3
5.1
–4
2.3
)
30
.3
 (2
4.6
–3
6.7
)
44
.6
 (4
0.0
–4
9.4
)
43
.3
 (3
7.0
–4
9.7
)
 
M
en
42
.4
 (3
5.8
–4
9.3
)
43
.0
 (3
7.4
–4
8.8
)
34
.5
 (2
6.1
–4
4.0
)
50
.6
 (4
2.2
–5
8.8
)
45
.5
 (3
5.8
–5
5.6
)
 
W
om
en
34
.4
 (3
0.2
–3
8.8
)
34
.7
 (3
0.8
–3
8.7
)
26
.2
 (1
9.9
–3
3.8
)
39
.4
 (3
2.6
–4
6.6
)
41
.5
 (3
5.6
–4
7.7
)
H
isp
an
ic
 
A
ll
77
.1
 (7
3.0
–8
0.7
)
77
.9
 (7
4.2
–8
1.3
)
71
.7
 (6
5.1
–7
7.6
)
84
.4
 (8
0.6
–8
7.5
)
78
.3
 (7
1.9
–8
3.5
)
 
M
en
77
.9
 (7
1.6
–8
3.1
)
78
.6
 (7
3.1
–8
3.2
)
73
.8
 (6
3.5
–8
2.0
)
84
.7
 (7
8.3
–8
9.5
)
77
.0
 (6
8.3
–8
3.9
)
 
W
om
en
76
.2
 (7
2.0
–7
9.9
)
77
.2
 (7
3.3
–8
0.6
)
69
.5
 (6
3.5
–7
4.9
)
84
.0
 (8
0.0
–8
7.4
)
79
.3
 (7
0.2
–8
6.1
)
O
be
se
 (A
ll G
ra
de
s, 
BM
I ≥
30
)
A
ll 
ra
ce
/H
isp
an
ic
 o
rig
in
 g
ro
up
sc
JAMA. Author manuscript; available in PMC 2016 February 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ogden et al. Page 15
%
 (9
5%
 C
I)
≥2
0 
y
20
–3
9 
y
40
–5
9 
y
≥6
0 
y
C
ru
de
A
ge
 A
dju
ste
db
 
A
ll
35
.1
 (3
2.3
–3
8.1
)
34
.9
 (3
2.0
–3
7.9
)
30
.3
 (2
6.6
–3
4.4
)
39
.5
 (3
6.1
–4
3.0
)
35
.4
 (3
1.3
–3
9.6
)
 
M
en
33
.7
 (3
0.9
–3
6.6
)
33
.5
 (3
0.7
–3
6.5
)
29
.0
 (2
3.9
–3
4.6
)
39
.4
 (3
6.0
–4
2.9
)
32
.0
 (2
7.5
–3
6.9
)
 
W
om
en
36
.5
 (3
2.9
–4
0.3
)
36
.1
 (3
2.6
–3
9.8
)
31
.8
 (2
8.3
–3
5.5
)
39
.5
 (3
5.1
–4
4.2
)
38
.1
 (3
2.2
–4
4.5
)
N
on
-H
isp
an
ic
 w
hi
te
 
A
ll
33
.4
 (2
9.7
–3
7.3
)
32
.6
 (2
9.0
–3
6.5
)
26
.2
 (2
1.6
–3
1.4
)
38
.7
 (3
4.2
–4
3.3
)
34
.0
 (2
9.4
–3
9.0
)
 
M
en
33
.1
 (3
0.4
–3
6.0
)
32
.4
 (2
9.6
–3
5.3
)
24
.6
 (1
9.1
–3
1.2
)
41
.1
 (3
7.5
–4
4.8
)
31
.8
 (2
6.6
–3
7.5
)
 
W
om
en
33
.7
 (2
8.1
–3
9.8
)
32
.8
 (2
7.4
–3
8.8
)
27
.8
 (2
1.9
–3
4.7
)
36
.3
 (2
9.4
–4
3.7
)
35
.9
 (2
8.5
–4
4.0
)
N
on
-H
isp
an
ic
 b
la
ck
 
A
ll
47
.8
 (4
4.4
–5
1.4
)
47
.8
 (4
4.4
–5
1.3
)
46
 (4
0.3
–5
1.8
)
49
.3
 (4
4.5
–5
4.2
)
48
.5
 (4
2.5
–5
4.6
)
 
M
en
37
.0
 (3
3.2
–4
1.0
)
37
.1
 (3
3.1
–4
1.3
)
34
.9
 (2
8.5
–4
1.9
)
38
.2
 (3
2.8
–4
3.9
)
39
.2
 (3
0.6
–4
8.5
)
 
W
om
en
56
.7
 (5
2.2
–6
1.1
)
56
.6
 (5
2.2
–6
0.9
)
55
.8
 (4
7.3
–6
4.0
)
58
.6
 (5
0.5
–6
6.2
)
54
.8
 (4
7.5
–6
1.9
)
N
on
-H
isp
an
ic
 A
sia
n
 
A
ll
10
.9
 (8
.3–
14
.3)
10
.8
 (8
.2–
14
.2)
11
.4
 (7
.3–
17
.6)
11
.4
 (8
.0–
16
.0)
 
 
8.
9 
(5.
0–
15
.3)
 
M
en
10
.4
 (7
.4–
14
.3)
10
.0
 (7
.1–
14
.0)
12
.0
 (6
.7–
20
.6)
11
.0
 (6
.7–
17
.6)
 
 
4.
9 
(1.
6–
13
.8)
d,e
 
W
om
en
11
.4
 (7
.5–
17
.0)
11
.4
 (7
.5–
17
.0)
10
.9
 (6
.0–
18
.9)
11
.8
 (6
.6–
20
.0)
11
.9
 (6
.1–
22
.1)
H
isp
an
ic
 
A
ll
42
.0
 (3
8.3
–4
5.7
)
42
.5
 (3
9.0
–4
6.0
)
39
.0
 (3
3.2
–4
5.2
)
46
.0
 (3
9.8
–5
2.3
)
42
.8
 (3
6.0
–4
9.8
)
 
M
en
40
.7
 (3
5.9
–4
5.7
)
40
.1
 (3
5.8
–4
4.6
)
42
.0
 (3
3.7
–5
0.8
)
39
.9
 (3
1.3
–4
9.2
)
37
.3
 (3
0.4
–4
4.7
)
 
W
om
en
43
.3
 (3
8.5
–4
8.1
)
44
.4
 (4
0.0
–4
8.8
)
35
.8
 (3
0.0
–4
2.0
)
51
.9
 (4
5.0
–5
8.7
)
47
.1
 (3
8.3
–5
6.1
)
A
bb
re
vi
at
io
n:
 B
M
I, 
bo
dy
 m
as
s i
nd
ex
, c
al
cu
la
te
d 
as
 w
ei
gh
t i
n 
ki
lo
gr
am
s d
iv
id
ed
 b
y 
he
ig
ht
 in
 m
et
er
s s
qu
ar
ed
.
a
D
at
a 
fro
m
 th
e 
N
at
io
na
l H
ea
lth
 a
nd
 N
ut
rit
io
n 
Ex
am
in
at
io
n 
Su
rv
ey
; e
sti
m
at
es
 a
re
 w
ei
gh
te
d.
b A
ge
 a
dju
ste
d b
y t
he
 di
rec
t m
eth
od
 to
 th
e 2
00
0 C
en
sus
 po
pu
lat
ion
, u
sin
g t
he
 ag
e g
rou
ps 
20
–3
9, 
40
–5
0, 
an
d 6
0 y
ear
s a
nd
 ol
de
r.
c I
nc
lu
de
s r
ac
e/
H
isp
an
ic
 o
rig
in
 g
ro
up
s n
ot
 sh
ow
n 
se
pa
ra
te
ly
.
d N
o.
 o
f c
as
es
 <
10
.
e R
el
at
iv
e 
sta
nd
ar
d 
er
ro
r >
30
%
 b
ut
 <
40
%
.
JAMA. Author manuscript; available in PMC 2016 February 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ogden et al. Page 16
Ta
bl
e 
5
Pr
ev
al
en
ce
 o
f H
ig
h 
Bo
dy
 M
as
s I
nd
ex
 (O
be
sit
y G
rad
es 
2 a
nd
 3)
 fo
r A
du
lts
 A
ge
d 2
0 Y
ea
rs 
or 
Ol
de
r b
y S
ex
, A
ge
, a
nd
 R
ac
e/H
isp
an
ic 
Or
igi
n, 
Un
ite
d S
tat
es,
 
20
11
–2
01
2a
%
 (9
5%
 C
I)
≥2
0 
y
20
–3
9 
y
40
–5
9 
y
≥6
0 
y
C
ru
de
A
ge
 A
dju
ste
db
O
be
se
 G
ra
de
s 2
 a
nd
 3
 (B
M
I ≥
35
)
A
ll 
ra
ce
/H
isp
an
ic
 o
rig
in
 g
ro
up
sc
 
A
ll
14
.5
 (1
2.8
–1
6.4
)
14
.5
 (1
2.8
–1
6.4
)
13
.6
 (1
1.5
–1
6.1
)
15
.7
 (1
3.4
–1
8.3
)
14
.0
 (1
1.1
–1
7.6
)
 
M
en
11
.9
 (9
.8–
14
.2)
11
.9
 (9
.9–
14
.2)
11
.9
 (9
.5–
14
.9)
12
.2
 (9
.1–
16
.3)
11
.2
 (7
.3–
16
.6)
 
W
om
en
17
.1
 (1
4.9
–1
9.4
)
17
.0
 (1
4.9
–1
9.3
)
15
.4
 (1
3.1
–1
8.0
)
19
.1
 (1
6.2
–2
2.3
)
16
.3
 (1
2.8
–2
0.6
)
N
on
-H
isp
an
ic
 w
hi
te
 
A
ll
13
.5
 (1
1.2
–1
6.2
)
13
.3
 (1
1.0
–1
6.0
)
11
.7
 (8
.9–
15
.4)
14
.8
 (1
2.0
–1
8.2
)
13
.4
 (1
0.0
–1
7.8
)
 
M
en
11
.3
 (9
.0–
14
.2)
11
.2
 (9
.0–
13
.9)
10
.0
 (7
.2–
13
.5)
12
.8
 (8
.6–
18
.6)
10
.9
 (7
.1–
16
.4)
 
W
om
en
15
.5
 (1
2.5
–1
9.1
)
15
.3
 (1
2.3
–1
8.9
)
13
.7
 (1
0.0
–1
8.3
)
16
.9
 (1
3.7
–2
0.7
)
15
.5
 (1
0.9
–2
1.6
)
N
on
-H
isp
an
ic
 b
la
ck
 
A
ll
23
.4
 (2
1.3
–2
5.6
)
23
.3
 (2
1.2
–2
5.5
)
24
.7
 (2
1.1
–2
8.6
)
23
.7
 (2
1.0
–2
6.8
)
20
.1
 (1
5.6
–2
5.4
)
M
en
16
.1
 (1
2.9
–1
9.9
)
15
.9
 (1
2.8
–1
9.6
)
18
.0
 (1
1.9
–2
6.2
)
15
.7
 (1
1.8
–2
0.6
)
12
.8
 (8
.4–
18
.9)
 
W
om
en
29
.3
 (2
6.3
–3
2.5
)
29
.2
 (2
6.3
–3
2.4
)
30
.6
 (2
6.5
–3
5.1
)
30
.4
 (2
6.1
–3
5.1
)
25
.0
 (1
9.7
–3
1.3
)
N
on
-H
isp
an
ic
 A
sia
n
 
A
ll
 
 
2.
4 
(1.
3–
4.4
)
 
 
2.
4 
(1.
3–
4.5
)
 
 
2.
5 
(1.
2–
4.8
)d,
e
 
 
2.
5 
(0.
8–
7.7
)d,
e
 
 
2.
4 
(0.
8–
6.5
)d,
e
 
M
en
 
 
1.
9 
(0.
9–
4.0
)d,
e
 
 
1.
7 
(0.
8–
3.4
)d,
e
 
 
3.
8 
(1.
7–
8.2
)d,
e
 
 
 
 
 
0d
 
 
0.
8 
(0.
1–
6.0
)d,
e
 
W
om
en
 
 
2.
9 
(1.
2–
7.1
)e
 
 
3.
0 
(1.
2–
7.1
)e
 
 
1.
1 
(0.
2–
5.4
)d,
e
 
 
4.
6 
(1.
3–
14
.6)
d,e
 
 
3.
6 
(1.
0–
11
.5)
d,e
H
isp
an
ic
 
A
ll
16
.0
 (1
3.7
–1
8.5
)
16
.2
 (1
4.0
–1
8.7
)
15
.0
 (1
0.6
–2
0.8
)
17
.2
 (1
3.0
–2
2.5
)
16
.7
 (1
1.9
–2
2.9
)
 
M
en
12
.4
 (9
.4–
16
.1)
11
.9
 (9
.5–
14
.8)
14
.9
 (8
.7–
24
.4)
 
 
8.
7 
(5.
0–
14
.7)
11
.9
 (8
.3–
17
.0)
 
W
om
en
19
.6
 (1
6.6
–2
3.1
)
20
.2
 (1
7.1
–2
3.7
)
15
.1
 (1
0.9
–2
0.6
)
25
.5
 (2
0.4
–3
1.4
)
20
.5
 (1
3.7
–2
9.5
)
O
be
se
 G
ra
de
 3
 (B
M
I ≥
40
)
A
ll 
ra
ce
/H
isp
an
ic
 o
rig
in
 g
ro
up
sc
JAMA. Author manuscript; available in PMC 2016 February 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ogden et al. Page 17
%
 (9
5%
 C
I)
≥2
0 
y
20
–3
9 
y
40
–5
9 
y
≥6
0 
y
C
ru
de
A
ge
 A
dju
ste
db
 
A
ll
 
 
6.
4 
(5.
2–
7.7
)
 
 
6.
4 
(5.
2–
7.7
)
 
 
5.
6 
(4.
4–
7.1
)
 
 
7.
7 
(6.
2–
9.4
)
 
 
5.
6 
(3.
8–
8.0
)
 
M
en
 
 
4.
4 
(2.
7–
7.0
)
 
 
4.
4 
(2.
8–
6.8
)
 
 
3.
5 
(2.
4–
5.2
)
 
 
5.
4 
(3.
1–
9.2
)
 
 
4.
1 
(1.
8–
8.8
)e
 
W
om
en
 
 
8.
3 
(7.
0–
9.8
)
 
 
8.
3 
(6.
9–
9.8
)
 
 
7.
7 
(6.
1–
9.7
)
 
 
9.
8 
(8.
3–
11
.6)
 
 
6.
8 
(4.
8–
9.4
)
N
on
-H
isp
an
ic
 w
hi
te
 
A
ll
 
 
5.
7 
(4.
2–
7.6
)
 
 
5.
6 
(4.
1–
7.5
)
 
 
4.
7 
(3.
1–
7.0
)
 
 
7.
0 
(4.
9–
9.8
)
 
 
5.
0 
(3.
2–
7.7
)
 
M
en
 
 
3.
9 
(1.
9–
7.6
)e
 
 
3.
8 
(1.
9–
7.2
)e
 
 
2.
6 
(1.
2–
5.6
)e
 
 
5.
2 
(2.
2–
11
.4)
e
 
 
3.
6 
(1.
5–
8.2
)e
 
W
om
en
 
 
7.
4 
(5.
7–
9.5
)
 
 
7.
4 
(5.
6–
9.7
)
 
 
6.
8 
(4.
4–
10
.4)
 
 
8.
8 
(7.
0–
10
.9)
 
 
6.
2 
(3.
8–
9.8
)
N
on
-H
isp
an
ic
 b
la
ck
 
A
ll
12
.2
 (1
0.4
–1
4.2
)
12
.1
 (1
0.3
–1
4.0
)
11
.9
 (1
0.4
–1
3.5
)
13
.8
 (1
0.8
–1
7.4
)
 
 
9.
5 
(6.
0–
14
.7)
 
M
en
 
 
7.
0 
(5.
3–
9.1
)
 
 
6.
9 
(5.
3–
8.9
)
 
 
5.
6 
(3.
5–
8.9
)
 
 
8.
9 
(6.
0–
13
.0)
 
 
5.
7 
(2.
7–
11
.7)
e
 
W
om
en
16
.5
 (1
3.5
–2
0.0
)
16
.4
 (1
3.5
–1
9.8
)
17
.5
 (1
4.6
–2
0.8
)
17
.9
 (1
3.2
–2
3.7
)
12
.1
 (7
.3–
19
.5)
N
on
-H
isp
an
ic
 A
sia
n
 
A
ll
 
 
0.
9 
(0.
3–
2.4
)d,
e
 
 
0.
9 
(0.
3–
2.3
)d,
e
 
 
0.
9 
(0.
2–
3.1
)d,
e
 
 
1.
0 
(0.
2–
4.4
)d,
e
 
 
0.
5 
(0.
1–
4.5
)d,
e
 
M
en
 
 
0.
3 
(0–
2.2
)d,
e
 
 
0.
2 
(0–
2.0
)d,
e
 
 
0.
6 
(0.
1–
5.2
)d,
e
 
 
 
 
 
0d
 
 
 
 
 
0d
 
W
om
en
 
 
1.
4 
(0.
5–
3.7
)d,
e
 
 
1.
4 
(0.
5–
3.6
)d,
e
 
 
1.
1 
(0.
2–
5.4
)d,
e
 
 
1.
9 
(0.
4–
8.5
)d,
e
 
 
1.
0 
(0.
1–
8.1
)d,
e
H
isp
an
ic
 
A
ll
 
 
5.
8 
(4.
7–
7.1
)
 
 
5.
8 
(4.
7–
7.1
)
 
 
5.
6 
(3.
9–
8.0
)
 
 
6.
0 
(4.
2–
8.6
)
 
 
5.
6 
(3.
0–
10
.0)
 
M
en
 
 
4.
1 
(3.
1–
5.6
)
 
 
3.
7 
(2.
7–
5.0
)
 
 
5.
4 
(3.
4–
8.5
)
 
 
2.
9 
(1.
5–
5.4
)d
 
 
2.
2 
(0.
6–
7.8
)d,
e
 
W
om
en
 
 
7.
4 
(5.
7–
9.5
)
 
 
7.
6 
(6.
0–
9.7
)
 
 
5.
8 
(3.
2–
10
.4)
 
 
9.
1 
(6.
3–
13
.1)
 
 
8.
2 
(4.
2–
15
.4)
e
A
bb
re
vi
at
io
n:
 B
M
I, 
bo
dy
 m
as
s i
nd
ex
, c
al
cu
la
te
d 
as
 w
ei
gh
t i
n 
ki
lo
gr
am
s d
iv
id
ed
 b
y 
he
ig
ht
 in
 m
et
er
s s
qu
ar
ed
.
a
D
at
a 
fro
m
 th
e 
N
at
io
na
l H
ea
lth
 a
nd
 N
ut
rit
io
n 
Ex
am
in
at
io
n 
Su
rv
ey
; e
sti
m
at
es
 a
re
 w
ei
gh
te
d.
b A
ge
 a
dju
ste
d b
y t
he
 di
rec
t m
eth
od
 to
 th
e 2
00
0 C
en
sus
 po
pu
lat
ion
, u
sin
g t
he
 ag
e g
rou
ps 
20
–3
9, 
40
–5
0, 
an
d 6
0 y
ear
s a
nd
 ol
de
r.
c I
nc
lu
de
s r
ac
e/
H
isp
an
ic
 o
rig
in
 g
ro
up
s n
ot
 sh
ow
n 
se
pa
ra
te
ly
.
d N
o.
 o
f c
as
es
 <
10
.
e R
el
at
iv
e 
sta
nd
ar
d 
er
ro
r >
30
%
 b
ut
 <
40
%
.
JAMA. Author manuscript; available in PMC 2016 February 29.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Ogden et al. Page 18
Ta
bl
e 
6
U
na
dju
ste
d T
est
s o
f L
ine
ar 
Tr
en
ds 
of 
Hi
gh
 W
eig
ht 
for
 Le
ng
tha
 
an
d 
O
be
sit
yb
,
c  
by
 A
ge
, U
ni
te
d 
St
at
es
, 2
00
3–
20
12
d
%
 (9
5%
 C
I)
C
ha
ng
e 2
00
3–
20
04
 to
 2
01
1–
20
12
, P
oi
nt
 (9
5%
 
C
I)e
P 
V
al
ue
f
20
03
–2
00
4
20
05
–2
00
6
20
07
–2
00
8
20
09
–2
01
0
20
11
–2
01
2
H
ig
h 
w
ei
gh
t f
or
 le
ng
th
 
(bi
rth
-<
2 y
)
 
A
ll
 
 
9.
5 
(7.
1 t
o 1
2.7
)
 
 
8.
2 
(6.
1 t
o 1
0.9
)
 
 
9.
5 
(7.
5 t
o 1
2)
 
 
9.
7 
(7.
6 t
o 1
2.3
)
 
 
8.
1 
(5.
8 t
o 1
1.1
)
−
1.
4 
(−
4.9
 to
 2.
1)
.
72
Ch
ild
ho
od
 o
be
sit
y,
 2
–1
9 
y
 
2–
19
17
.1
 (1
4.6
 to
 20
)
15
.4
 (1
2.8
 to
 18
.5)
16
.8
 (1
4.3
 to
 19
.7)
16
.9
 (1
5.4
 to
 18
.4)
16
.9
 (1
4.9
 to
 19
.2)
−
0.
2 
(−
3.4
 to
 3)
.
78
 
2–
5
13
.9
 (1
0.8
 to
 17
.6)
10
.7
 (8
.5 
to 
13
.3)
10
.1
 (7
.8 
to 
12
.9)
12
.1
 (9
.9 
to 
14
.8)
 
 
8.
4 
(5.
9 t
o 1
1.6
)
−
5.
5 
(−
9.6
 to
 −1
.4)
.
03
 
6–
11
18
.8
 (1
6.2
 to
 21
.7)
15
.1
 (1
1.3
 to
 20
.1)
19
.6
 (1
7.2
 to
 22
.4)
18
.0
 (1
6.3
 to
 19
.8)
17
.7
 (1
4.5
 to
 21
.4)
−
1.
1 
(−
5.2
 to
 3.
0)
.
88
 
12
–1
9
17
.4
 (1
4 t
o 2
1.3
)
17
.8
 (1
4.2
 to
 22
)
18
.1
 (1
4.7
 to
 22
)
18
.4
 (1
5.8
 to
 21
.3)
20
.5
 (1
7.1
 to
 24
.4)
 
 
3.
1 
(−
1.
7 
to
 7
.9
)
.
20
A
du
lt 
ob
es
ity
, ≥
20
 y
 
≥2
0
32
.2
 (2
9.7
 to
 34
.8)
34
.3
 (3
1.5
 to
 37
.3)
33
.7
 (3
1.5
 to
 36
.1)
35
.7
 (3
3.8
 to
 37
.7)
34
.9
 (3
2 t
o 3
7.9
)
 
 
2.
8 
(−
0.
8 
to
 6
.4
)
.
09
 
20
–3
9
28
.5
 (2
5.3
 to
 31
.9)
29
.1
 (2
5 t
o 3
3.7
)
30
.7
 (2
6.6
 to
 35
.1)
32
.6
 (2
9 t
o 3
6.4
)
30
.3
 (2
6.6
 to
 34
.4)
 
 
1.
9 
(−
2.
8 
to
 6
.6
)
.
20
 
40
–5
9
36
.8
 (3
3 t
o 4
0.8
)
40
.4
 (3
6.1
 to
 44
.7)
36
.2
 (3
2.8
 to
 39
.8)
36
.6
 (3
4.5
 to
 38
.7)
39
.5
 (3
6.1
 to
 43
)
 
 
2.
7 
(−
2.
1 
to
 7
.5
)
.
78
 
≥6
0
31
.0
 (2
8.2
 to
 33
.9)
33
.4
 (3
1.1
 to
 35
.9)
35
.1
 (3
2.9
 to
 37
.3)
39
.7
 (3
6.6
 to
 42
.9)
35
.4
 (3
1.3
 to
 39
.6)
 
 
4.
4 
(−
0.
3 
to
 9
.1
)
.
00
4
a
H
ig
h 
w
ei
gh
t f
or
 le
ng
th
 d
ef
in
ed
 a
s a
t o
r a
bo
ve
 th
e 
95
th
 p
er
ce
nt
ile
 o
n 
th
e s
ex
-s
pe
ci
fic
 C
en
te
rs
 fo
r D
ise
as
e C
on
tro
l a
nd
 P
re
ve
nt
io
n 
(C
DC
) 2
00
0 g
row
th 
ch
art
s.
b O
be
sit
y 
fo
r y
ou
th
 a
ge
d 
2 
to
 1
9 
ye
ar
s d
ef
in
ed
 as
 b
od
y 
m
as
s i
nd
ex
 (B
M
I) 
at 
or 
ab
ov
e t
he
 95
th 
pe
rce
nti
le 
on
 th
e C
DC
 se
x-s
pe
cif
ic 
BM
I f
or 
ag
e g
row
th 
ch
art
s.
c O
be
sit
y 
in
 a
du
lts
 d
ef
in
ed
 a
s B
M
I ≥
30
.
d D
at
a 
fro
m
 th
e 
N
at
io
na
l H
ea
lth
 a
nd
 N
ut
rit
io
n 
Ex
am
in
at
io
n 
Su
rv
ey
.
e P
er
ce
nt
ag
e 
po
in
ts.
f Fr
om
 th
e 
t t
es
t.
JAMA. Author manuscript; available in PMC 2016 February 29.
